| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034452 |
| Receipt No. | R000039283 |
| Scientific Title | Intravoxel Incoherent Motion MRI for Discrimination of Synovial Proliferation in the Hand of Rheumatoid Arthritis |
| Date of disclosure of the study information | 2018/10/12 |
| Last modified on | 2021/10/13 (Ver. 3) |
| Basic information | ||
| Public title | Intravoxel Incoherent Motion MRI for Discrimination of Synovial Proliferation in the Hand of Rheumatoid Arthritis | |
| Acronym | MRI for Rheumatoid Arthritis | |
| Scientific Title | Intravoxel Incoherent Motion MRI for Discrimination of Synovial Proliferation in the Hand of Rheumatoid Arthritis | |
| Scientific Title:Acronym | MRI for Rheumatoid Arthritis | |
| Region |
|
|
| Condition | |||
| Condition | Rheumatoid Arthritis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To test the capability of intravoxel incoherent motion (IVIM) MRI to noninvasively discriminate synovial proliferation in the hand of patients with rheumatoid arthritis (RA). |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | contrast-enhanced MRI as gold standard examination |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with suspected RA who have pain and/or swelling of the hands | |||
| Key exclusion criteria | Those who are contraindicated to contrast MRI | |||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hokkaido University | ||||||
| Division name | Faculty of Health Sciences | ||||||
| Zip code | 060-0812 | ||||||
| Address | North-12, West-5, Kita-ku, Sapporo , Japan | ||||||
| TEL | 011-706-2824 | ||||||
| ktamotamo2@hs.hokudai.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hokkaido University | ||||||
| Division name | Faculty of Health Sciences | ||||||
| Zip code | 060-0812 | ||||||
| Address | North-12, West-5, Kita-ku, Sapporo 060-0812, Japan | ||||||
| TEL | 011-706-2824 | ||||||
| Homepage URL | |||||||
| ktamotamo2@hs.hokudai.ac.jp | |||||||
| Sponsor | |
| Institute | Hokkaido University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hokkaido University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hokkaido University |
| Address | North-12, West-5, Kita-ku, Sapporo 060-0812, Japan |
| Tel | +81117063315 |
| ktamotamo2@hs.hokudai.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | IVIM will be performed using ten b values. Contrast enhanced MRI was evaluated using a grading scale of 0 to 4 according to the degree of contrast enhancement on the area indicating high signal intensity on STIR images. We will calculate the apparent diffusion coefficient value and IVIM parameters, thereafter, these parameters will be compared between synovial proliferation and joint effusion, according to the grading scale using the Spearman rank correlation test and receiver operating characteristic curve. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000039283 |